Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingfei Ma

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Cancers|May 25, 2024
A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS)Li Wang, Yao Ding, Teresa L Bruno, et al.
Scientific Reports|July 2, 2025
A follow-up study on the novel use of contrast-enhanced susceptibility-weighted imaging for extremity desmoid fibromatosis response assessmentRaul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Journal for Immunotherapy of Cancer|November 30, 2019
Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCCAliya Qayyum, Ken-Pin Hwang, Jason Stafford, et al.
Cancers|February 10, 2024
A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation TherapyLi Wang, Jeremiah Sanders, John F Ward, et al.
JCO Clinical Cancer Informatics|January 22, 2025
Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment ResponseRaul F Valenzuela, Elvis de Jesus Duran Sierra, Mathew A Canjirathinkal, et al.
Radiology. Imaging Cancer|September 3, 2021
Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot StudyShu Zhang, Gaiane M Rauch, Beatriz E Adrada, et al.
Cancer Research|August 1, 2022
MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerChengyue Wu, Angela M Jarrett, Zijian Zhou, et al.
Science Translational Medicine|November 11, 2011
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeysKirstin F Barnhart, Dawn R Christianson, Patrick W Hanley, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2025
Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECISTRaul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Brachytherapy|April 9, 2020
Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignanciesMatthew S Ning, Sastry Vedam, Jingfei Ma, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Cancers|May 25, 2024
A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS)Li Wang, Yao Ding, Teresa L Bruno, et al.
Scientific Reports|July 2, 2025
A follow-up study on the novel use of contrast-enhanced susceptibility-weighted imaging for extremity desmoid fibromatosis response assessmentRaul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Journal for Immunotherapy of Cancer|November 30, 2019
Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCCAliya Qayyum, Ken-Pin Hwang, Jason Stafford, et al.
Cancers|February 10, 2024
A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation TherapyLi Wang, Jeremiah Sanders, John F Ward, et al.
JCO Clinical Cancer Informatics|January 22, 2025
Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment ResponseRaul F Valenzuela, Elvis de Jesus Duran Sierra, Mathew A Canjirathinkal, et al.
Radiology. Imaging Cancer|September 3, 2021
Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot StudyShu Zhang, Gaiane M Rauch, Beatriz E Adrada, et al.
Cancer Research|August 1, 2022
MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerChengyue Wu, Angela M Jarrett, Zijian Zhou, et al.
Science Translational Medicine|November 11, 2011
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeysKirstin F Barnhart, Dawn R Christianson, Patrick W Hanley, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2025
Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECISTRaul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Brachytherapy|April 9, 2020
Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignanciesMatthew S Ning, Sastry Vedam, Jingfei Ma, et al.
Pageof 12